Flow Dynamic Factors Correlated With Device-Related Thrombosis After Left Atrial Appendage Occlusion
- PMID: 39493311
- PMCID: PMC11530902
- DOI: 10.1016/j.jacadv.2024.101339
Flow Dynamic Factors Correlated With Device-Related Thrombosis After Left Atrial Appendage Occlusion
Abstract
Background: Device-related thrombosis (DRT) occurs in up to 4% of patients undergoing left atrial appendage occlusion (LAAO) and is associated with substantial morbidity and mortality. However, its pathophysiology, predictors, and optimal management remain unclear.
Objectives: This study aims to assess flow dynamic factors correlating to DRT.
Methods: A multicenter registry of patients who underwent LAAO and had pre- and post-computed tomography imaging was used. Patient-specific 3-dimensional digital models of the left atrium were created, and finite element simulations were performed to implant an LAAO device into each model in a position that matched the clinical deployment. Computational fluid dynamic simulations were performed to quantify the following flow dynamic parameters: time averaged wall shear stress, oscillatory shear index, and endothelial cell activation potential.
Results: A total of 38 patients (19 with DRT and 19 without DRT) were included. Left atrium volumes and mitral valve areas were larger in the DRT cohort compared with controls. Patients with DRT had a significantly lower time averaged wall shear stress (1.76 ± 1.24 Pa vs 2.90 ± 2.70 Pa), a higher oscillatory shear index (0.19 ± 0.11 vs 0.17 ± 0.11), and a higher endothelial cell activation potential (0.23 ± 0.58 Pa-1 vs 0.17 ± 0.30 Pa-1) than the controls (P < 0.001 for all). Thrombus locations identified from in-vivo images correlated well with the flow dynamic parameters tested.
Conclusions: Flow dynamic parameters may be able to predict the risk of DRT after LAAO. Further investigation with a larger patient cohort and long-term follow-up is needed to assess the role of computational fluid dynamics in the risk stratification of patients considered for LAAO.
Keywords: DRT; LAAO; device-related thrombosis; left atrial appendage occlusion; thrombosis.
© 2024 The Authors.
Conflict of interest statement
This research was partly supported by the American Heart Association (AHA) under award number 24CDA1269661. Dr De Backer has received consulting fees and institutional research grants from 10.13039/100000046Abbott and 10.13039/100008497Boston Scientific. Dr Nielsen-Kudsk has received institutional research grants from 10.13039/100000046Abbott, 10.13039/100008497Boston Scientific, and the 10.13039/501100009708Novo Nordic Foundation. Dr Bavo is an employee of FEops. Dr De Beule is a shareholder of FEops. Dr Vogl was partially supported by the 10.13039/100001502Blue Cross Blue Shield of Michigan Foundation, the DeVlieg Foundation, and the Health Research Institute fellowship at Michigan Tech. Dr Jia has received a scholarship from China Scholarship Council under the State Scholarship Fund of China. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures




References
-
- Reddy V.Y., Doshi S.K., Kar S., et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70:2964–2975. - PubMed
-
- Holmes D.R., Jr., Alkhouli M., Reddy V. Left atrial appendage occlusion for the unmet clinical needs of stroke prevention in nonvalvular atrial fibrillation. Mayo Clin Proc. 2019;94:864–874. - PubMed
-
- Alkhouli M., Alqahtani F., Aljohani S., Alvi M., Holmes D.R. Burden of atrial fibrillation–associated ischemic stroke in the United States. JACC Clin Electrophysiol. 2018;4:618–625. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous